SCHEMBL5679783

SCHEMBL5679783

Nc1nc2cc(-c3ccc(Cl)cc3)ccc2[nH]1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BACE1 P56817 2/20 0.59
HTR3E A5X5Y0 1/20 0.59
HTR3B O95264 1/20 0.59
HTR3A P46098 1/20 0.59
HTR3D Q70Z44 1/20 0.59
HTR3C Q8WXA8 1/20 0.59
MEN1 O00255 2/20 0.47
ALDH1A1 P00352 2/20 0.47
KMT2A Q03164 2/20 0.47
MASP2 O00187 1/20 0.47
NUDT1 P36639 1/20 0.47
AOC3 Q16853 1/20 0.47
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
KDM4E B2RXH2 2/20 0.46
TP53 P04637 1/20 0.46
APP P05067 1/20 0.46
GAA P10253 1/20 0.46
MAPT P10636 1/20 0.46
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13894857 0.85 HTR3E (0.51) BACE1HTR3EHTR3BHTR3AHTR3D
SCHEMBL216615 0.85 HTR3E (0.72) BACE1HTR3EHTR3BHTR3AHTR3D
SCHEMBL117352 0.85 BACE1 (0.54) BACE1HTR3EHTR3BHTR3AHTR3D
SCHEMBL3827667 0.84 ALDH1A1 (0.58) BACE1HTR3EHTR3BHTR3AHTR3D
SCHEMBL14655239 0.84 HTR3E (0.49) BACE1HTR3EHTR3BHTR3AHTR3D
Bromide SCHEMBL2381776 0.84 BACE1 (0.53) BACE1HTR3EHTR3BHTR3AHTR3D
Bromide SCHEMBL215261 0.84 HTR3E (0.70) BACE1HTR3EHTR3BHTR3AHTR3D
SCHEMBL5679426 0.83 FABP6 (0.53) BACE1HTR3EHTR3BHTR3AHTR3D
SCHEMBL16848371 0.83 JAK2 (0.50) BACE1HTR3EHTR3BHTR3AHTR3D
SCHEMBL5679606 0.83 ALDH1A1 (0.47) BACE1HTR3EHTR3BHTR3AHTR3D

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1620413-A2 COMPOUNDS, COMPOSITIONS, AND METHODS Cytokinetics, Inc. (US) 2006-02-01 EP disclosed
WO-2004098494-A2 COMPOUNDS, COMPOSITIONS, AND METHODS CYTOKINETICS, INC. (US) 2004-11-18 WO disclosed